XOMA Royalty Corporation - SIC # 6794 - PATENT OWNERS AND LESSORS

Ticker Exchange SIC # Website Latest Ticker
XOMA Nasdaq 6794 www.xoma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for XOMA Royalty Corporation

XOMA Royalty Announces CFO Transition - Jan 12th, 2026 5:30 am
Implied Volatility Surging for XOMA Royalty Stock Options - Jan 5th, 2026 6:48 am
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab - Dec 30th, 2025 5:30 am
XOMA Royalty Declares Quarterly Preferred Stock Dividends - Dec 22nd, 2025 5:30 am
XOMA Royalty (NASDAQ:XOMA) shareholders have earned a 13% CAGR over the last three years - Dec 21st, 2025 5:47 am
XOMA Royalty Enters into Agreement to Acquire Generation Bio - Dec 15th, 2025 3:00 pm
Huge Insider Buying in MGM and Salesforce - Dec 12th, 2025 7:45 am
Xoma Crumbles And Partner Rezolute Collapses On Failed Insulin Disease Drug - Dec 11th, 2025 4:41 pm
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - Dec 5th, 2025 7:00 am
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition - Dec 5th, 2025 5:45 am
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - Nov 26th, 2025 7:00 am
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - Nov 21st, 2025 5:45 am
XOMA Royalty's (NASDAQ:XOMA) Earnings Aren't As Good As They Appear - Nov 19th, 2025 3:44 am
Earnings Beat: XOMA Royalty Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Nov 15th, 2025 5:41 am
A Note On XOMA Royalty Corporation's (NASDAQ:XOMA) ROE and Debt To Equity - Nov 14th, 2025 4:12 am
XOMA Royalty (XOMA) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 6:45 am
TScan Therapeutics, Inc. (TCRX) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 6:25 am
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements - Nov 12th, 2025 5:30 am
LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline - Nov 10th, 2025 2:09 pm
Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates - Nov 4th, 2025 8:15 am